Hypersensitivity Reactions to Docetaxel: Retrospective Evaluation and Development of a Desensitization Protocol-Reference-Cited by-同舟云学术

Hypersensitivity Reactions to Docetaxel: Retrospective Evaluation and Development of a Desensitization Protocol

Published:2011 Issue:3 Volume:156 Page:320-324
ISSN:1423-0097
Container-title:International Archives of Allergy and Immunology
language:en
Short-container-title:Int Arch Allergy Immunol

Author:

Syrigou Ekaterini,Dannos Ioannis,Kotteas Elias,Makrilia Nektaria,Tourkantonis Ioannis,Dilana Kalliopi,Gkiozos Ioannis,Saif Muhammad Wasif,Syrigos Kostas N.

Publisher

S. Karger AG

Subject

Immunology,General Medicine,Immunology and Allergy

Reference33 articles.

1. Hypersensitivity Reactions to Chemotherapeutic Drugs

2. 10. Drug allergy

3. Hypersensitivity reactions to oxaliplatin and other antineoplastic agents

4. Successful re-treatment with taxol after major hypersensitivity reactions.

5. Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative study of dexamethasone premedication regimens with docetaxel chemotherapy in early HER-2 positive breast cancer: A safety net hospital experience;Journal of Oncology Pharmacy Practice;2024-02-29

2. Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions;European Journal of Clinical Pharmacology;2023-12-15

3. Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of Desensitization;Clinical Reviews in Allergy & Immunology;2023-08-17

4. Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer;Journal for Research in Applied Sciences and Biotechnology;2023-06-12

5. A Three-Step Taxane Titration Protocol Decreases Hypersensitivity Reactions During First and Second Exposures;JCO Oncology Practice;2023-06